The global cancer burden is increasing rapidly in developing countries where populations continue to expand. The lack of resources and basic health infrastructure means that most people in developing countries have no access to cancer screening, early diagnosis, treatment or palliative care. Many patients are frequently sent home to die without comfort or palliative care. It is therefore of utmost importance to develop an affordable, reliable, accurate and sensitive cancer biomarker device to detect cancer at an early stage.